Birmingham OB/Gyn Integrates Heart Disease Risk Screening Into Mammograms

What Happened

Birmingham OB/Gyn has introduced a diagnostic tool that identifies breast arterial calcifications during standard mammography exams. By using AI-driven software, the clinic can now detect potential markers for cardiovascular issues without requiring additional medical appointments or radiation exposure.

The program, titled Mammo with Heart, utilizes CureMetrix cmAngio technology to analyze existing imaging files. This allows clinicians to spot signs of arterial health concerns that might otherwise go unnoticed during routine breast cancer screenings.

To support patients flagged for elevated risk, the practice has established a referral network with the Alabama Cardiovascular Group. This ensures that women identified through the screening process receive timely access to specialized cardiac evaluations and preventive care strategies.

The Core Points

AI-assisted analysis detects breast arterial calcifications during routine mammograms
No extra radiation or patient appointments required for the screening
Partnership with Alabama Cardiovascular Group ensures follow-up care for high-risk findings
Addresses heart disease as a leading cause of death among Alabama women
Technology utilizes existing FDA-cleared cmAngio software to provide dual health insights

Context in 60 Seconds

Medical providers are increasingly shifting toward multidisciplinary screening models that maximize the utility of routine diagnostic tests. By leveraging artificial intelligence to analyze incidental findings in common imaging procedures, healthcare facilities can identify chronic disease risks earlier without increasing the burden on the patient.

This trend reflects a broader push in preventive medicine to address heart disease—the primary cause of mortality for women in the United States—by utilizing existing patient touchpoints. Integrating cardiovascular risk assessment into established gynecological care pathways aims to improve long-term outcomes through early intervention.

Bottom Line

Patients at Birmingham OB/Gyn can now receive a cardiovascular risk assessment as part of their standard annual mammogram. This combined approach facilitates earlier detection of heart disease and streamlines the path to specialized care.

Loading briefing details...

Birmingham OB/Gyn Integrates Heart Disease Risk Screening Into Mammograms

What Happened

The Core Points

AI-assisted analysis detects breast arterial calcifications during routine mammograms
No extra radiation or patient appointments required for the screening
Partnership with Alabama Cardiovascular Group ensures follow-up care for high-risk findings
Addresses heart disease as a leading cause of death among Alabama women
Technology utilizes existing FDA-cleared cmAngio software to provide dual health insights